Combined molecular lipophilicity descriptors and their role in understanding intramolecular effects

Pharmaceutical Science and Technology Today

Volumn 2, Issue 8, 1999, Pages 327-335

  Caron, Giulia ^a   Reymond, Frédéric ^b   Carrupt, Pierre Alain ^a   Girault, Hubert H ^b   Testa, Bernard ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Laboratoire d'Electrochimie Physique et Analytique EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL STRUCTURE; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEN BOND; LIPOPHILICITY; MOLECULAR INTERACTION; PARTITION COEFFICIENT; PH; PHYSICAL CHEMISTRY; POTENTIOMETRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; TITRIMETRY;

EID: 0033179099     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00180-7     Document Type: Review

References (68)

1. Dewar M.J.S., McKee M.L. J. Am. Chem. Soc. 100:1978;7499-7505.
2. Smith D.A., Jones B.C., Walker D.K. Med. Res. Rev. 16:1996;243-266.
3. Testa B., Kier L.B., Carrupt P.A. Med. Res. Rev. 17:1997;303-327.
4. Abraham M.H. Chem. Soc. Rev. 1993;73-83.
5. Abraham M.H., Chadha H.S. Pliska V., Testa B., van de Waterbeemd H. Lipophilicity in Drug Action and Toxicology. 1996;311-337 VCH Publishers, Weinheim, Germany.
6. Leahy D.E., Taylor P.J., Wait A.R. Quant. Struct.-Act. Relatsh. 8:1989;17-31.
7. Pagliara A.et al. J. Chem. Soc., Perkin Trans. 2:1997;2639-2643.
8. Steyaert G.et al. J. Chem. Soc., Faraday Trans. 93:1997;401-406.
9. El Tayar N.et al. J. Pharm. Sci. 80:1991;590-598.
10. Abraham M.H.et al. J. Pharm. Sci. 83:1994;1085-1100.
11. Young R.C.et al. J. Med. Chem. 31:1988;656-671.
12. El Tayar N.et al. J. Pharm. Sci. 80:1991;744-749.
13. Abraham M.H., Chadha H.S., Mitchell R.C. J. Pharm. Sci. 83:1994;1257-1268.
14. von Geldern T.W.et al. J. Med. Chem. 39:1996;982-991.
15. Yoshida F., Topliss J.G. J. Pharm. Sci. 85:1996;819-823.
16. Caron G.et al. Helv. Chim. Acta. 79:1996;1683-1685.
17. Caron G.et al. Pharm. Res. 13:1996;1186-1190.
18. Pagliara A.et al. J. Med. Chem. 41:1998;853-863.
19. Testa B.et al. Pliska V., Testa B., van de Waterbeemd H. Lipophilicity in Drug Action and Toxicology. 1996;49-71 VCH Publishers, Weinheim, Germany.
20. Testa B.et al. Pharm. Res. 13:1996;335-343.
21. Gaillard P., Carrupt P.A., Testa B. Bioorg. Med. Chem. Lett. 4:1994;737-742.
22. Carrupt, P.A., Testa, B. & Gaillard, P. (1997) in Reviews in Computational Chemistry (Vol. 11) (Boyd, D.B. & Lipkowitz, K.B., eds), pp. 241-315, Wiley-VCH, New York, NY, USA.
23. Caron G.et al. Helv. Chim. Acta. 80:1997;449-462.
24. Brunner-Guenat M.et al. J. Pharm. Pharmacol. 47:1995;861-869.
25. Dearden J.C., Bresnen G.M. Quant. Struct.-Act. Relatsh. 7:1988;133-144.
26. Hersey A.et al. Quant. Struct.-Act. Relatsh. 8:1989;288-296.
27. Krämer S.D., Gautier J.C., Saudemon P. Pharm. Res. 15:1998;1310-1313.
28. Reymond F.et al. Chem. Eur. J. 5:1999;39-47.
29. McFarland J.M.R.et al. J. Med. Chem. 40:1997;1340-1346.
30. Takacs-Novak K., Avdeef A. J. Pharm. Biomed. Anal. 14:1996;1405-1413.
31. Slater B.et al. J. Pharm. Sci. 83:1994;1280-1283.
32. Avdeef A.et al. J. Med. Chem. 39:1996;4377-4381.
33. Avdeef A. Pliska V., Testa B., van de Waterbeemd H. Lipophilicity in Drug Action and Toxicology. 1996;109-139 VCH Publishers, Weinheim, Germany.
34. Fruttero R.et al. Pharm. Res. 15:1998;1407-1413.
35. Avdeef A.et al. Pharm. Res. 15:1998;209-215.
36. Avdeef A. Quant. Struct.-Act. Relatsh. 11:1992;510-517.
37. Avdeef A.et al. Anal. Chem. 54:1982;2322-2326.
38. Reymond F.et al. J. Electroanal. Chem. 424:1997;121-139.
39. Reymond F.et al. J. Am. Chem. Soc. 118:1996;11951-11957.
40. Vallat P.et al. J. Liq. Chromatogr. 15:1992;2133-2151.
41. Bechalany A.et al. J. Chromatogr. 473:1989;115-124.
42. Sabatka J.J.et al. J. Chromatogr. 384:1987;349-356.
43. Barbato F.et al. Farmaco. 45:1990;647-663.
44. Pagliara A.et al. J. Liq. Chromatogr. 18:1995;1721-1745.
45. van de Waterbeemd H.et al. Pliska V., Testa B., van de Waterbeemd H. Lipophilicity in Drug Action and Toxicology. 1996;73-87 VCH Publishers, Weinheim, Germany.
46. Tsai R.S.et al. Pliska V., Testa B., van de Waterbeemd H. Lipophilicity in Drug Action and Toxicology. 1996;89-107 VCH Publishers, Weinheim, Germany.
47. El Tayar N.et al. J. Chromatogr. 556:1991;181-194.
48. Ito Y. Mandava N.B., Ito Y. Countercurrent Chromatography. Theory and Practice. 1988;79-442 Marcel Dekker, Inc, New York, NY, USA.
49. Reymond F.et al. Helv. Chim. Acta. 79:1996;101-117.
50. Rekker R.F., Mannhold R. Calculation of Drug Lipophilicity. 1992;14-34 VCH Publishers, Weinheim, Germany.
51. Kubinyi H. Mannhold R., Krogsgaard-Larsen P., Timmerman H. QSAR: Hansch Analysis and Related Approaches. 1993;80-81 VCH Publishers, Weinheim, Germany.
52. Murthy K.S., Zograti G. J. Pharm. Sci. 59:1970;1281-1285.
53. Caron G.et al. Helv. Chim. Acta. . (in press).
54. Cheymol G.et al. J. Clin. Pharmacol. 27:1987;874-879.
55. Kobayashi I.et al. Biol. Pharm. Bull. 20:1997;421-427.
56. Yamada Y.et al. Biol. Pharm. Bull. 16:1993;1251-1259.
57. Drayer D.E. Pharmacotherapy. 7:1987;61-87.
58. Ferrari S., Leemann T., Dayer P. Life Sci. 48:1991;2259-2265.
59. Tsai R.S.et al. J. Chem. Soc., Perkin Trans. 2:1991;1797-1802.
60. Takacs-Novak K., Jozan M., Szasz G. Int. J. Pharm. 113:1995;47-55.
61. Hatanaka T.et al. Int. J. Pharm. 125:1995;195-203.
62. Abraham M.H., Takacs-Novak K., Mitchell R.C. J. Pharm. Sci. 86:1997;310-315.
63. Pagliara A.et al. Chem. Rev. 97:1997;3385-3400.
64. Lin J.H., Lu A.Y.H. Pharmacol. Rev. 49:1997;403-449.
65. Seydel J.K. Meth. Fin. Exp. Clin. Pharmacol. 6:1984;571-581.
66. Walther B., Vis P., Taylor A. Pliska V., Testa B., van de Waterbeemd H. Lipophilicity in Drug Action and Toxicology. 1996;253-261 VCH Publishers, Weinheim, Germany.
67. Giroud Y.et al. Helv. Chim. Acta. 81:1998;330-341.
68. Chopineaux-Courtois V.et al. J. Am. Chem. Soc. 121(8):1999;1743-1747.